Hans Eckart Schaefer
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Immunology top 5%
- Macrophage Migration Inhibitory Factor
- Immune Response and Inflammation
Papers in
- Genetics 16
- Chronic Lymphocytic Leukemia Research 9
- Myeloproliferative Neoplasms: Diagnosis and Treatment 8
- Hematology 15
- Chronic Myeloid Leukemia Treatments 11
- Acute Myeloid Leukemia Research 5
- Co-authors
- Christian H. Ihling (10 shared papers)Andreas Michael Zeiher (6 shared papers)Gustav Fraedrich (4 shared papers)Jürgen Bernhagen (2 shared papers)Anke Burger‐Kentischer (2 shared papers)Robert Kleemann (2 shared papers)K. Decker (3 shared papers)H.‐J. Schlayer (3 shared papers)
- Journals
- The Journal of Pathology (4 papers)Acta Haematologica (4 papers)Annals of Hematology (2 papers)Circulation (2 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
Hans Eckart Schaefer
64 papers receiving 2.0k citations
Hans Eckart Schaefer's Hit Papers
Peers
Comparison fields: 5 of 101
- Hematology 537
- Immunology 555
- Genetics 205
- Cancer Research 136
- Hepatology 70
Countries citing papers authored by Hans Eckart Schaefer
This map shows the geographic impact of Hans Eckart Schaefer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Eckart Schaefer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Eckart Schaefer more than expected).
Fields of papers citing papers by Hans Eckart Schaefer
This network shows the impact of papers produced by Hans Eckart Schaefer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Eckart Schaefer. The network helps show where Hans Eckart Schaefer may publish in the future.
Co-authors
The 25 scholars most cited alongside Hans Eckart Schaefer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Low-Dose Decitabine Versus Best Supportive Care in Elderly Patients With Intermediate- or High-Risk Myelodysplastic Syndrome (MDS) Ineligible for Intensive Chemotherapy: Final Results of the Randomized Phase III Study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group Hit paper breakdown → | 2011 | 474 |
| 2 | 2002 | 232 | |
| 3 | 1988 | 140 | |
| 4 | 1988 | 124 | |
| 5 | 2005 | 115 | |
| 6 | 2001 | 110 | |
| 7 | 1998 | 96 | |
| 8 | 1997 | 93 | |
| 9 | 2002 | 62 | |
| 10 | 1996 | 58 | |
| 11 | 1999 | 58 | |
| 12 | 1991 | 53 | |
| 13 | 1985 | 45 | |
| 14 | 2001 | 44 | |
| 15 | 1996 | 38 | |
| 16 | 1996 | 35 | |
| 17 | 2000 | 25 | |
| 18 | 1988 | 25 | |
| 19 | 2004 | 22 | |
| 20 | 1994 | 21 |
About Hans Eckart Schaefer
Hans Eckart Schaefer is a scholar working on Genetics, Hematology, Immunology, Physiology and Rheumatology, having authored 68 papers that have together received 2.1k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (11 papers), Chronic Lymphocytic Leukemia Research (9 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers), Eosinophilic Disorders and Syndromes (5 papers), Acute Myeloid Leukemia Research (5 papers), Hematological disorders and diagnostics (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Microbial infections and disease research (3 papers). The work is most often cited by research in Hematology (537 citations), Immunology (555 citations), Genetics (205 citations), Cancer Research (136 citations) and Hepatology (70 citations). Hans Eckart Schaefer has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Christian H. Ihling, Andreas Michael Zeiher, Gustav Fraedrich, Jürgen Bernhagen, Anke Burger‐Kentischer, Robert Kleemann, K. Decker, H.‐J. Schlayer, Michael Lübbert and Heike Goebel. Their work appears in journals such as The Journal of Pathology, Acta Haematologica, Annals of Hematology, Circulation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.